MELIS, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 194.812
NA - Nord America 9.369
AS - Asia 3.544
SA - Sud America 648
Continente sconosciuto - Info sul continente non disponibili 385
AF - Africa 107
OC - Oceania 46
Totale 208.911
Nazione #
IT - Italia 192.771
US - Stati Uniti d'America 9.164
SG - Singapore 1.394
CN - Cina 1.120
BR - Brasile 481
SE - Svezia 456
UA - Ucraina 450
VN - Vietnam 295
GB - Regno Unito 248
DE - Germania 220
FI - Finlandia 212
FR - Francia 191
CA - Canada 128
HK - Hong Kong 125
IN - India 121
BD - Bangladesh 82
KR - Corea 65
AR - Argentina 63
MX - Messico 46
NL - Olanda 45
PH - Filippine 40
IQ - Iraq 39
AU - Australia 38
PL - Polonia 34
TR - Turchia 32
ZA - Sudafrica 31
JP - Giappone 29
EC - Ecuador 26
AT - Austria 25
ES - Italia 24
IL - Israele 23
PK - Pakistan 23
ID - Indonesia 21
IE - Irlanda 21
CO - Colombia 20
BE - Belgio 19
MA - Marocco 19
MY - Malesia 18
SA - Arabia Saudita 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
CL - Cile 16
IR - Iran 15
RU - Federazione Russa 15
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
CR - Costa Rica 9
EG - Egitto 9
TN - Tunisia 9
CH - Svizzera 8
EU - Europa 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
AZ - Azerbaigian 7
GR - Grecia 7
HU - Ungheria 7
AL - Albania 6
BO - Bolivia 6
LK - Sri Lanka 6
LT - Lituania 6
NG - Nigeria 6
PT - Portogallo 6
TH - Thailandia 6
ET - Etiopia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
HN - Honduras 2
MT - Malta 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DM - Dominica 1
Totale 208.517
Città #
Cagliari 188.925
Uta 3.375
Fairfield 894
Ashburn 815
Singapore 708
Woodbridge 628
San Jose 460
Dallas 381
Houston 372
Seattle 343
Chandler 339
Ann Arbor 320
Boardman 309
Wilmington 303
Cambridge 283
Nyköping 278
Jacksonville 235
Beijing 222
Council Bluffs 185
Los Angeles 169
Dearborn 148
Helsinki 129
New York 125
The Dalles 125
Santa Clara 119
Hong Kong 110
Ho Chi Minh City 100
Lauterbourg 95
Boston 87
Nanjing 81
Shanghai 78
Hefei 67
Buffalo 66
Hanoi 65
Seoul 59
San Diego 58
Atlanta 57
Orem 48
Guangzhou 46
London 46
Dong Ket 36
San Francisco 36
Toronto 36
Milan 35
São Paulo 35
Denver 34
Nanchang 34
Munich 33
Redwood City 32
Columbus 30
Hebei 28
Brooklyn 27
Phoenix 27
Chicago 26
Shenyang 26
Frankfurt am Main 25
Warsaw 25
Rome 24
Tianjin 24
Jiaxing 22
Chennai 21
Dublin 21
Montreal 21
Redondo Beach 21
Tokyo 21
Norwalk 20
Changsha 19
Mountain View 19
Johannesburg 18
Mexico City 17
Mumbai 15
Brussels 14
Melbourne 14
Washington 14
Jinan 13
Newark 13
Vienna 13
Falls Church 12
Haverhill 12
Philadelphia 12
Santiago 12
Stockholm 12
Zhengzhou 12
Amsterdam 11
Augusta 11
Baghdad 11
Buenos Aires 11
Curitiba 11
Dhaka 11
Guayaquil 11
Kunming 11
Manchester 11
Quezon City 11
Tashkent 11
Belo Horizonte 10
Nuremberg 10
Orange 10
Porto Alegre 10
Pune 10
Brasília 9
Totale 202.394
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.779
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.444
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.147
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.185
Maternal immune activation disrupts dopamine system in the offspring 4.164
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.623
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.491
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.365
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.329
Editorial: Exploring gender and sex differences in behavioral dyscontrol: From drug addiction to impulse control disorders 3.230
Sex differences in addictive disorders 3.189
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.052
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 3.036
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.963
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.749
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.734
New vistas on cannabis use disorder 2.652
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 2.636
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.629
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.611
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.575
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.566
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.473
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.467
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system 2.450
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.392
Sex differences in impulsive and compulsive behaviors: a focus on drug addiction 2.370
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction 2.358
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.320
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.187
Rehabilitating the addicted brain with transcranial magnetic stimulation 2.114
Altered chloride homeostasis decreases the action potential threshold and increase hyperexcitability in hippocampal neurons 2.045
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.017
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.866
Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids 1.811
Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission 1.810
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.781
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.781
Optogenetic inhibition of chemically induced hypersynchronized bursting in mice 1.764
Endocannabinoids and lipid mediators in brain functions 1.738
null 1.722
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.668
Gender differences in the outcome of offspring prenatally exposed to drugs of abuse 1.624
Consequences of Perinatal Cannabis Exposure 1.573
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects 1.541
Exercise craving potentiates excitatory inputs to ventral tegmental area dopaminergic neurons 1.484
The endocannabinoid system and nondrug rewarding behaviours 1.462
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.453
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.429
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.418
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.369
Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure 1.207
Role of 2-arachidonoylglycerol-mediated plasticity at inhibitory synapses onto midbrain dopamine neurons in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.194
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.172
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission 1.166
The dopamine hypothesis of drug addiction: hypodopaminergic state 1.157
COR758, a negative allosteric modulator of GABAB receptors 1.155
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.137
I CANNABINOIDI ATTIVANO I NEURONI DOPAMINERGICI DEL SISTEMA MESOLIMBICOCORTICALE 1.135
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.128
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.105
Endocannabinoids and the processing of value-related signals 1.091
Fatty acid ethanolamides pinpoint nicotinic receptors and modulate neuronal excitability through nuclear receptor PPARα 1.085
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.064
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.041
A role for midbrain 2-arachidonoylglycerol signalling in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.033
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement 1.004
Use of marijuana: effect on brain health and cognitive impairment 1.002
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 949
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 922
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 894
Endocannabinoids mediate pre-synaptic inhibition of glutamatergic transmission in rat VTA DA neurons through activation of CB1 receptors 866
null 850
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 845
null 841
From surface to nuclear receptors: the endocannabinoid family extends its assets 822
null 800
Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure 794
Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure 784
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 754
null 747
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 742
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 727
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 722
Presynaptic nanoscale components of retrograde synaptic signaling 698
Ethanol and acetaldehyde action on central dopamine systems: mechanisms,modulation and relation to stress 671
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system 665
Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system 653
Different mechanism for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain 644
Electrophysiological effects of cannabinoids in the basal ganglia 591
Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone 584
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids 582
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 577
COX- Inhibitors increase morphine effects on mesolimbic dopamine neurons 567
Clozapine potently stimulates mesocortical dopamine neurons 566
Clozapine does activate does activate nigrostriatal dopamine neurons in unanesthetized rats 546
The cyclo-oxygenase inhibitor nimesulide induce conditioned place preference in rats 545
Mesolimbic dopaminergic decline after cannabinoid withdrawal 542
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 540
Totale 204.936
Categoria #
all - tutte 256.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 256.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.202 0 872 524 643 961 948 668 629 703 1.176 1.700 1.378
2022/202313.360 1.214 1.460 1.306 1.203 1.281 1.552 708 863 872 966 1.295 640
2023/202448.380 728 645 508 850 1.311 2.110 2.292 816 738 935 1.547 35.900
2024/202525.799 6.367 7.059 2.767 2.653 1.356 1.950 2.063 184 367 239 558 236
2025/20268.065 626 328 1.000 721 507 606 1.265 394 589 942 711 376
2026/20271.657 750 907 0 0 0 0 0 0 0 0 0 0
Totale 208.911